NONOF:OTCMKTS
Novo Nordisk A/S
US$ ३८.१५
arrow_downward
-०.५१%(-०.१९) 1D
सेप्टेम्बर ३०, १६:००:०० GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NONOF...
Open
US$ ३८.०१
High
US$ ३८.५३
Low
US$ ३७.९१
Mkt. cap
१.२८ खरब
Avg. vol.
१.३५ लाख
Volume
११.१८ हजार
52-wk high
US$ ६४.७५
52-wk low
US$ ३४.००
Beta
०.६३
Shares outstanding
३.३९ अरब
No. of employees
६७ हजार
Open
US$ ३८.०१
High
US$ ३८.५३
Low
US$ ३७.९१
Mkt. cap
१.२८ खरब
Avg. vol.
१.३५ लाख
Volume
११.१८ हजार
52-wk high
US$ ६४.७५
52-wk low
US$ ३४.००
Beta
०.६३
Shares outstanding
३.३९ अरब
No. of employees
६७ हजार
News stories
From web sources and news partners
The Motley Fool
·
४ घण्टा पहिले
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy
Reuters
·
५ घण्टा पहिले
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial
Stocks Down Under
·
८ घण्टा पहिले
Missed Out On The Eli Lilly & Novo Nordisk GLP-1 Boom? These 7 Stocks Could Benefit Next!
The Globe and Mail
·
१२ घण्टा पहिले
Could This Company Challenge Eli Lilly and Novo Nordisk in the Weight Loss Market?
Profile
Novo is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. Wikipedia
About Novo Nordisk A/S
CEOMaziar Mike Doustdar
Employees६६.७ हजार
Founded१९२३ डिसेम्बर २१
HeadquartersBagsværd, Capital Region of Denmark, डेनमार्क
Sector-
Websitenovonordisk.com